Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Judice Insider Profile
4 Followers
Kevin Judice, Director at Cidara Therapeutics, holds 0.00 shares in Dice Therapeutics (Ticker: DICE), holds 94.49K shares in Cidara Therapeutics (Ticker: CDTX).
Kevin Judice has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Kevin Judice holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Judice
Kevin Judice's Trading History
Cidara Therapeutics
Apr 14, 2015
Director
Uninformative Buy
―
$1.93M
Dice Therapeutics
Aug 09, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Kevin Judice's performance on stock
You May Also Like
Kevin Judice insider profile FAQ
What is the percentage of profitable transactions made by Kevin Judice?
The percentage of profitable transactions made by Kevin Judice is ―.
What is the average return per transaction made by Kevin Judice?
The average return per transaction made by Kevin Judice is ―.
What stocks does Kevin Judice hold?
Kevin Judice holds: CDTX, DICE stocks.
What was Kevin Judice’s latest transaction?
Kevin Judice latest transaction was an Uninformative Sell of ―.
What was Kevin Judice's most profitable transaction?
Kevin Judice’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Judice's role in Cidara Therapeutics?
Kevin Judice's role in Cidara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.